All Stories

  1. Mitoxyperilysis: fasting-induced cell death in immunometabolism and disease
  2. ALPK1 agonists ignite innate immunity in anticancer therapy
  3. Inflammation and cell death drive Monkeypox-induced viral pathogenesis
  4. A potent NLRP3 inhibitor effective against both MCC950-sensitive and -resistant inflammation
  5. Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11
  6. Ferroptosis-activating metabolite acrolein antagonizes necroptosis and anti-cancer therapeutics
  7. Protocol for the processing, cryopreservation, and biobanking of patient-derived cells and tissues
  8. Interferon signalling and non-canonical inflammasome activation promote host protection against multidrug-resistant Acinetobacter baumannii
  9. Cardiolipin Inhibits the Noncanonical Inflammasome by Preventing LPS Binding to Caspase 4/11 to Mitigate Endotoxemia in Vivo
  10. Inflammasome protein scaffolds the DNA damage complex during tumor development
  11. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis
  12. Author Correction: Caspase-1-dependent inflammasomes mediate photoreceptor cell death in photo-oxidative damage-induced retinal degeneration
  13. Innate immune sensing of cell death in disease and therapeutics
  14. Mouse guanylate-binding proteins of the chromosome 3 cluster do not mediate antiviral activity in vitro or in mouse models of infection
  15. NLRC5 PANoptosome: Aquaman of the Dead Sea
  16. A TNIP1-driven systemic autoimmune disorder with elevated IgG4
  17. NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance
  18. Ku70 senses cytosolic DNA and assembles a tumor-suppressive signalosome
  19. Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice
  20. Interferon signalling and non-canonical inflammasome activation promote host protection against multidrug-resistant Acinetobacter baumannii
  21. Ku70 senses cytosolic DNA and assembles a tumor-suppressive signalosome
  22. DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency
  23. A High-Throughput Screen Identifies New Drugs for the Treatment of Lymphoma
  24. Impairing Gasdermin D-mediated pyroptosis is protective against retinal degeneration
  25. Guanylate-binding proteins: mechanisms of pattern recognition and antimicrobial functions
  26. Clostridium perfringens virulence factors are nonredundant activators of the NLRP3 inflammasome
  27. Cell death and barrier disruption by clinically used iodine concentrations
  28. Mouse guanylate‐binding protein 1 does not mediate antiviral activity against influenza virus in vitro or in vivo
  29. Immunity against Moraxella catarrhalis requires guanylate‐binding proteins and caspase‐11‐ NLRP3 inflammasomes
  30. Primary Intestinal Fibroblasts: Isolation, Cultivation, and Maintenance
  31. Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains
  32. GBP1 promotes killing of multidrug-resistantAcinetobacter baumanniiand promotes host protection via interferon signalling and inflammasome activation
  33. Peer Review Week 2022: an interview with Rafal Marszalek, Si Ming Man and Guideng Li about their views on research integrity as scientists and editors
  34. Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia
  35. Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling
  36. Clostridium septicum α-toxin activates the NLRP3 inflammasome by engaging GPI-anchored proteins
  37. Gallium–Strontium Phosphate Conversion Coatings for Promoting Infection Prevention and Biocompatibility of Magnesium for Orthopedic Applications
  38. Mpeg1 is not essential for antibacterial or antiviral immunity, but is implicated in antigen presentation
  39. Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains
  40. Streptococcus makes the cut: Gasdermin A-induced pyroptosis
  41. Context-dependent functions of pattern recognition receptors in cancer
  42. Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway
  43. Cell biology of inflammasome activation
  44. Viperin has species-specific roles in response to herpes simplex virus infection
  45. Multi-omics of the esophageal microenvironment identifies signatures associated with progression of Barrett’s esophagus
  46. Bacillus cereus: Epidemiology, Virulence Factors, and Host–Pathogen Interactions
  47. Activation mechanisms of inflammasomes by bacterial toxins
  48. Publisher Correction: Captain GBP1: inflammasomes assemble, pyroptotic endgame
  49. Molecular mechanisms activating the NAIP‐NLRC4 inflammasome: Implications in infectious disease, autoinflammation, and cancer
  50. Captain GBP1: inflammasomes assemble, pyroptotic endgame
  51. MicroRNA-223 Regulates Retinal Function and Inflammation in the Healthy and Degenerating Retina
  52. Gasdermins deliver a deadly punch to cancer
  53. Caspase-1-dependent inflammasomes mediate photoreceptor cell death in photo-oxidative damage-induced retinal degeneration
  54. Bacillus cereus non-haemolytic enterotoxin activates the NLRP3 inflammasome
  55. The Ribosomal Biogenesis Inhibitor CX-5461 Is an Anti-Cancer Therapeutic That Increases Platelet Count in Mice and in Humans
  56. Emerging Activators and Regulators of Inflammasomes and Pyroptosis
  57. DDX3X: stressing the NLRP3 inflammasome
  58. IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases
  59. A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome
  60. The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β Activation
  61. ALPK1: innate attraction to the sweetness of bacteria
  62. Cytosolic Recognition of Microbes and Pathogens: Inflammasomes in Action
  63. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
  64. Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death
  65. Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome Responses during Francisella novicida Infection
  66. Mechanisms and functions of guanylate-binding proteins and related interferon-inducible GTPases: Roles in intracellular lysis of pathogens
  67. Molecular mechanisms of inflammasome signaling
  68. NLRP9b: a novel RNA-sensing inflammasome complex
  69. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
  70. Differential roles of caspase-1 and caspase-11 in infection and inflammation
  71. Inflammasomes and Cancer
  72. NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
  73. Regulation of lysosomal dynamics and autophagy by CTSB/cathepsin B
  74. IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes
  75. Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection
  76. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways
  77. Interferon-inducible guanylate-binding proteins at the interface of cell-autonomous immunity and inflammasome activation
  78. DOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection
  79. DNA-sensing inflammasomes: regulation of bacterial host defense and the gut microbiota
  80. Type I Interferon Keeps IL-1β in Check
  81. AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity
  82. Converging roles of caspases in inflammasome activation, cell death and innate immunity
  83. Gasdermin D: the long-awaited executioner of pyroptosis
  84. Is Campylobacter to esophageal adenocarcinoma as Helicobacter is to gastric adenocarcinoma?
  85. Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
  86. Global Epidemiology of Campylobacter Infection
  87. A20 is a regulator of necroptosis
  88. Regulation of inflammasome activation
  89. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection
  90. Concerted Activation of the AIM2 and NLRP3 Inflammasomes Orchestrates Host Protection against Aspergillus Infection
  91. Campylobacter
  92. Transcriptomic and Proteomic Analyses Reveal Key Innate Immune Signatures in the Host Response to the Gastrointestinal Pathogen Campylobacter concisus
  93. Actin polymerization as a key innate immune effector mechanism to control Salmonella infection
  94. Role of Emerging Campylobacter Species in Inflammatory Bowel Diseases
  95. Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation
  96. Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex
  97. Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection
  98. Salmonella Infection Induces Recruitment of Caspase-8 to the Inflammasome To Modulate IL-1  Production
  99. Functional relationship between Campylobacter concisus and the stomach ecosystem in health and disease
  100. Bacterial infection of macrophages induces decrease in refractive index
  101. The clinical importance of emerging Campylobacter species
  102. Stats for papers let authors track impact
  103. Correction: The role of bacteria and pattern-recognition receptors in Crohn's disease
  104. The role of bacteria and pattern-recognition receptors in Crohn's disease
  105. Host Attachment, Invasion, and Stimulation of Proinflammatory Cytokines by Campylobacter concisus and Other Non– Campylobacter jejuni Campylobacter Species
  106. Detection of Helicobacteraceae in Intestinal Biopsies of Children with Crohn’s Disease
  107. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohnʼs disease
  108. The Internal Transcribed Spacer Region, a New Tool for Use in Species Differentiation and Delineation of Systematic Relationships within the Campylobacter Genus
  109. The secretome of Campylobacter concisus
  110. Campylobacter concisus: a New Character in the Crohn's Disease Story?
  111. Detection and Isolation of Campylobacter Species Other than C. jejuni from Children with Crohn's Disease
  112. Detection of Enterohepatic and Gastric Helicobacter Species in Fecal Specimens of Children with Crohn's Disease